Bone Marrow Transplantation

Papers
(The H4-Index of Bone Marrow Transplantation is 26. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
When is a chimaera not a chimaera?116
The 49th Annual Meeting of the European Society for Blood and Marrow Transplantation: Data Management Group – Poster Session (P725-P741)93
The 49th Annual Meeting of the European Society for Blood and Marrow Transplantation: Van Bekkum Awards75
Haploidentical-cord blood stem cell transplantation versus haploidentical stem cell transplantation for non-CR acute leukemia patients: a multicenter study69
OBITUARY- Riccardo Saccardi (20th April 1956–19th February 2024)68
Adding 5-day decitabine to the conditioning regimen for haploidentical bone marrow transplantation in aplastic anaemia patients results in satisfactory clinical outcomes60
Tandem hematopoietic stem cell transplant considerations in families with multiple siblings affected by DOCK8 deficiency58
Prognostic impact of histopathologic features including histological grading and immunohistochemistry-positive cell counts in cytomegalovirus-gastrointestinal disease after allogeneic hematopoietic ce53
The 51st Annual Meeting of the European Society for Blood and Marrow Transplantation: Pharmacist Committee – Poster Session (P919-P930)42
Role of extracorporeal photopheresis in the management of acute and chronic graft versus disease: current status41
DNA methylation in circulating leukocytes is a novel biomarker in multiple myeloma41
Real world experience using belumosudil for treatment of chronic graft versus host disease in children and young adults38
Low-dose post-transplant cyclophosphamide with low-dose antithymocyte globulin for prevention of graft-versus-host disease in first complete remission undergoing 10/10 HLA-matched unrelated donor peri38
Length of SARS-CoV-2 shedding in HCT recipients: an Infectious Disease Working Party of EBMT study38
Autologous stem cell boost improves persistent immune effector cell associated hematotoxicity following BCMA directed chimeric antigen receptor T (CAR T) cell therapy in multiple myeloma38
T cell redirection as a new standard of care for relapsed multiple myeloma: impact on inpatient capacity, financial burden and infrastructural requirements in Germany37
Patient-generated strategies for strengthening adherence to multiple medication regimens after allogeneic stem cell transplantation: a qualitative study32
The impact of social determinants of health on outcomes of brexucabtagene autoleucel in adults with relapsed/refractory B-cell acute lymphoblastic leukemia31
Intermediate-dose TBI/fludarabine conditioning for allogeneic hematopoietic cell transplantation in patients with peripheral T-cell lymphoma31
Addition of ruxolitinib to standard graft-versus-host disease prophylaxis for allogeneic stem cell transplantation in aplastic anemia patients30
Late hematologic toxicity after CAR T-cell therapy in large B-cell lymphoma: incidence, risk factors, and clinical impact30
CD28-costimulated CD19 CAR-T cells for pediatric mature non-Hodgkin B-cell lymphoma30
Cytokine release syndrome: implications for transplant outcomes in haploidentical and HLA-matched HSCT using PTCy30
Defining remission and relapse after allogeneic hematopoietic cell transplantation in myelodysplastic/myeloproliferative neoplasms and optimization of transplantation outcomes: Recommendations from th29
Randomized phase 2 study of digital life coaching during transplantation for myeloma27
Palliative care involvement for pediatric hematopoietic cell transplant patients can enhance comfort-focused care at end of life without shortening survival duration27
Artificial intelligence methods to estimate overall mortality and non-relapse mortality following allogeneic HCT in the modern era: an EBMT-TCWP study26
Infection prevention practices among EBMT hematopoietic cell transplant centers: the EBMT Infectious Disease Working Party survey26
The cellular composition and function of the bone marrow niche after allogeneic hematopoietic cell transplantation26
0.096401929855347